PNSA can reverse EMT of breast cancer cells and enhance the killing ability to breast cancer cells of NK cells by downregulation of PD-L1, which is better than 17-AAG, let alone PNSA is less toxic to NK cells than 17-AAG. Here, CD274 is linked to breast carcinoma.